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ХІЛОТОРАКС В ОНКОХВОРИХ: СПОСОБИ ЛІКУВАННЯ
On the basis o f dom estic and foreign scien tific  publications considered m ethods o f d iagnosis and treatm ent of  
chylothorax in cancer patients. From clinical positions evaluated conservative treatm ent, duct em bolization, and 
surgical thoracic duct ligation . It is concluded that chylothorax is life-threaten ing com plication that postpones 
time o f the special anticancer treatm ent. Therefore, when a chylothorax is occurred in cancer patients the active 
surgical tactics as the thoracic lym phatic duct ligation  should be done.
У статті на основі вітчизняних і зарубіжних наукових публікацій розглянуто методи діагностики та лікування 
хілотораксу в онкохворих. З клінічних позицій оцінено консервативне лікування, емболізацію  і хірургічну 
перев’язку грудної лімфатичної протоки. Зроблено висновок, що хілоторакс — це життєво небезпечне ускладнення, 
яке віддаляє час проведення спеціального протипухлинного лікування. Тому при виникненні хілотораксу в 
онкохворого слід дотримуватись активної хірургічної тактики — виконувати перев’язку грудної лімфатичної 
протоки після правобічної торакотомії або з використанням відеоторакоскопічної техніки.
Chylothorax is a presence of lymph in pleural cavity 
which is accumulated in it because o f damage of 
thoracic lymph duct. Chylothorax belongs to the 
complications potentially dangerous for life and is 
accompanied with the respiratory changes, metabolic 
and immunologic imbalance. Over the last 10-15 years 
diagnostic capabilities and therapeutic approach 
considerably changed, which let successfully fight with 
such difficult complication now [1, 20-21, 24].
E tio lo g y . Thoracic lymph duct (TLD) injuries occur 
not so often (1.0-4.0 %) after surgeries in thorax and 
dilated cervical lymphadenectomies [1, 3, 20]. According 
to Merigliano and co-authors (2000), chylothorax 
occurred in 19 patients (1.1 %) of 1787 operated for 
cancer of oesophagus or cardia of stomach [14].
Chylothorax may be caused by traumatic and non­
traumatic etiological factors. Traumatic chylothorax is a 
complication of surgery: most often after esophagectomy 
in patien ts w ith oesophagus cancer (41.3 %), 
pulmonectomy or lobectomy (10.3 %), chest injury 
(6.9 %), thymomectomy, cervical lymphodissections 
(Crile’s operation or casing-fascial lymphadenectomy) 
[2, 8, 11, 16, 22, 24].
Non-traumatic chylothorax sometimes occurs at 
lym phoproliferatire  d isorders with the prim ary 
localization of tumors in mediastinum (17.2 %), during
obstruction of the upper vena cava, at malignant tumors 
of pleura, in the process of cytostatic chemotherapy or 
radiation treatm ent o f the chest in patients with 
lymphomas and breast cancer [1, 6, 17-18, 21].
D i a g n o s t i c s . C linically injuries o f TLD are 
appeared with chylothorax, chylopericardium  or 
cervical lymphatic fistula. Patient has dispnea, during 
percussion -  dullness o f lung sound, auscultation -  
weak or absence of breathing on the affected side. 
On an x-ray picture and CT there is an effusion in 
the pleural cavity with the mediastinal displacement 
and compression o f lung. At thoracocentesis they get 
milk-like with chylomicrons liquid, without any smell. 
Chylous exudates contains high concen tra tion  
triglycerides (>1.24 mmol/l) [1-3, 20].
Postoperative (traumatic) chylothorax is diagnosed 
with some delay (2-5 days) which is connected with 
the intravenous infusion therapy that is actual parenteral 
nutrition o f the patient. I f  drainages are present in 
pleural cavity chylorrhea may be found the next day 
after the surgery [17, 18].
C o n se rv a tiv e  trea tm en t. Treatment of chylothorax 
depends on its aetiology and volume of daily lymph 
discharge. Traditionally conservative therapy includes 
fatless diet, parenteral nutrition, daily monitoring of 
liquid and electrolytes, drainage o f pleural cavity (or
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repeated punctures of pleural cavity with the maximum 
possible evacuation of chylous liquid), replacement of 
lymph losses. Change to the full parenteral nutrition is 
the most effective for reduction of lymphopoiesis. After 
liquid evacuation intrapleural injection of antibiotics for 
prevention of infection o f pleural cavity is essential [8, 
10, 15, 20, 21].
Some authors recommend to carry out reinfusion 
of lymph 0.8—1.5 l per one procedure, 2-4  times with a 
break in 2-3 days [1]. “Octreotide” is used for the 
pharmacological blockage o f lymphopoiesis. This 
preparation increases the resistance of microcirculatory 
course in abdominal cavity and reduces gastrointestinal 
secretion. Almost in 50 % (from 25 to 75 %) of cases 
conservative approach is effective and chylorrhea stops 
during 10-14 days [1, 21].
Conservative treatm ent is based on the pecu­
liarities o f lymph composition and chylopoiesis. Lipids 
are the main constituent component of lymph; 60­
70 % o f consumed fat is absorbed by the intestinal 
lymphatic system and through thoracic duct gets into 
the bloodstream. Extravascular protein returns to the 
blood stream  through thoracic duct too; protein 
content in lymph is half o f its concentration in blood 
plasma. The main cellular elements o f lymph are 
lymphocytes, 90 % of them is T-lymphocytes. That 
is why prolonged chylorrhea of the thoracic duct leads 
to hypoproteinemia, lymphocytopenia, electrolyte 
imbalance, immune, metabolic, nutritional and general 
exhaustion [1, 20, 21]. Prolonged conservative 
treatment o f chylothorax is associated with mortality 
in 50-82 % of cases. Results o f surgical ligation of 
lymphatic duct are more encouraging with 10-16 % 
o f mortality rate [10, 24].
Still, there is no consensus on the optimal duration 
of non-surgical period. It is believed that if this approach 
does not bring any success, operative measures (ligation 
o f the thoracic duct) should be taken. Surgical 
methods are used only when there is no response to 
medical therapy or when lymph loss is more than 500­
1000 ml/day [10, 17].
T h o ra c ic  d u c t  e m b o liza tio n . In order to visualize 
the lym phatic ducts it is necessary  to  perform  
lymphangiography. First, catheterization o f lymph 
vessels in the feet using lymphotropic dye indigocarmin 
or lymphazurin is performed; then contrast medium 
lipiodol is injected intralymphatically. Thoracic duct 
begins with cisterna chyli which is located in the 
abdomen at the level of L1-L2 (behind the right crus 
of diaphragm). From radiological point of view during 
lymphangiography cisterna chyli is seen as an oblong 
sack 2.0 x 1.0 cm. With the help o f interventional 
radiology, percutaneous transabdominal cannulation
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(catheterization) of cisterna chyli or thoracic duct is 
performed. In this case, spiral ring is inserted into the 
lumen of thoracic duct which serves as a support for 
polymerization material n-Butyl cyanoacrylate (n-BCA), 
which is actually used to embolize duct lumen. The 
efficiency of thoracic duct embolization ranges from 
69 to 91 % [5, 12]. In one of the studies lymphangio­
graphy was not only a diagnostic but also therapeutic 
procedure in eight of the nine patients [13]. That is, 
the procedure of diagnostic lymphangiography itself can 
stop lymph leakage in the thoracic cavity, and, thus, 
surgical intervention (thoracotomy) can be avoided. 
Lymphangiography is recommended in cases when 
conservative treatment of chylothorax will not probably 
be effective [9, 13].
Percutaneous embolization o f thoracic duct is 
ind ica ted  in cases when there  is high risk  o f 
complications after rethoracotomy. According to Cope 
(2004), after thoracic duct embolization had been 
performed, chylorrhea completely ceased during the 
first week in 61.5 % of patients, and during the next 
two weeks in 23.0 % of patients [7]. In another report, 
chylothorax was eliminated in 69.0 % of patients [12]. 
Thoracic duct embolization has become an important 
therapeutic alternative due to its high efficiency level 
with minimal complications [5]. I f  percutaneous 
embolization is not successful, surgical ligation of 
thoracic duct or pleurodesis should be performed [12].
S u r g ic a l  t r e a tm e n t  -  l ig a t io n  o f  th e  th o r a c ic  
duct. Timing o f the operation still remains disputable. 
The indications for surgery  are the following: 
chylothorax lasting for 1-3 weeks, or daily lymph loss 
more than  500 ml. M ost surgeons believe tha t 
(re)operation should be performed immediately after 
diagnosing chylothorax or within 48 hours if  intensive 
conservative treatment is not effective [15, 19, 20, 
24]. The choice of the technique depends on surgeon’s 
qualification, existing clinical equipment, and results 
o f previous surgical interventions. The following 
methods are used: direct ligation o f the thoracic duct, 
supradiaphragm atic dressing “ad m asum ” o f the 
thoracic duct, video-assisted thoracoscopic ligation of 
the thoracic duct, pleurodesis, pleural-peritoneal 
bypass. As for the access, u sua lly  righ t-side , 
sometimes left-side thoracotom y is used; video- 
assisted thoracoscopy has also become preferable 
recently [17, 21, 23].
Video-assisted ligation o f thoracic duct is an 
effective method for chylothorax elimination and has 
minimal complications [6, 10]. If  chylorrhea is higher 
than 1000 ml per day, there are all indications for early 
thoracoscopic ligation of the thoracic duct [18, 23]. Early 
reoperations with thoracic duct ligations, in the
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comparison with the delayed ones, do not cause fatal 
complications, and usually are successful [17, 19]. Early 
ligation is the operation of choice in cases when chylo- 
thorax occurs after esophagectomy [14]. If  chylorrhea 
does not stop after ligation of the thoracic duct has been 
performed, pleurodesis is indicated [17, 21].
The standard surgical operation involves precision 
dissection of tissues in the location of the thoracic duct 
in the lower posterior mediastinum and further ligation 
of the thoracic duct above and below the defect. The 
thoracic duct is sutured and bandaged in the typical 
location between the aorta and azygos vein at the level 
o f ThX-ThXI vetebrae [1, 18, 21]. In the case of 
impossibility to identify the place of rupture, a continuous 
stitch is sutured a wound on the paraaortic tissues in 
the typical place on the right side at the ThX vertebra 
level [1, 2].
The plastic surgery o f the damaged area of the 
thoracic duct with the application of the microsurgical 
anastomosis or lymphovenous anastomosis between 
the thoracic duct and azygos vein is performed at some 
clinics [2, 3].
For intraoperative identification o f the damaged 
area o f the thoracic duct location, the fat mixture, 
dyed by indigo carmine, is injected through the 
nasoenteric tube or 200.0 ml o f milk with 20.0 grams 
o f  m argarine  is given to  drink  to  the p a tien t 
immediately before the surgery. In case I, lymph is 
dyed in blue colour, in case II lymph gets intensive 
milky white colour, and it allows to identify the location 
o f the thoracic duct defect [1, 16].
R udim entary  postopera tive  lym phorrhea is 
observed in some patients, they are exposed to the 
pleural cavity puncture, lymph evacuation and pleural 
sclerosant injections (doxycycline, hypertonic glucose 
solution) [1, 17].
Surgical pleurodesis is effective in some cases and 
it may be the method of choice for critically ill patients 
[17]. In severe cases, when the damaged place of the 
thoracic duct can not be identified, pleurodesis is the 
only method of chylothorax elimination [18].
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